+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
| Target | SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) |
| Research Area | Infection Immunity |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | ELISA, WB, SDS-PAGE |
| Host | Mammalian cells |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Purity | > 90% (SDS-PAGE) |
| Storage | Store at -20°C to -80°C. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| NCBI Accession | UFO69279.1 |
| Molecular Weight | Calculated MW: 24.86 kDa |
| Sequence Fragment | Thr333-Gly526 |
| Tag | C-terminal His tag |
| Buffer | Prior to lyophilization: PBS, pH 7.5. |
| Standard Form | Recombinant SARS-CoV-2 S Protein RBD (1.1.529/Omicron) is produced by Mammalian cells expression system and the target gene encoding Thr333-Gly526 is expressed with C-His Tag. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |